Investigating How the RECT Impacts Brain Functional States Through the ACC-cerebellar Loop
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
Experiment1: Using a brain EEG-TMS combined system, researchers aim to investigate the impact of the rostral anterior cingulate cortexr (rACC)-engaging cognitive task (RECT) combined single-pulse TMS magnetic stimulation on theta neural oscillations in the medial frontal lobe. The study will be divided into 4 groups: the first group will receive left cerebellar single-pulse TMS stimulation combined with the RECT task, the second group will receive right cerebellar single-pulse TMS stimulation combined with the RECT task, the third group will receive midline cerebellar single-pulse TMS stimulation combined with the RECT task, and the fourth group will receive sham cerebellar single-pulse TMS stimulation combined with the RECT task. Divide the participants into groups of 15 people each, following a 1:1:1:1 ratio. Based on the above testing, the stimulus method that results in the most significant change in the midline of the frontal lobe will be identified. Experiment 2: Based on the research from Experiment 1, the most significant approach affecting theta neural oscillations in the medial frontal gyrus will be identified. This stimulation protocol will be combined with left dorsolateral prefrontal cortex iTBS stimulation in Experiment 2. The research aim of Experiment 2 is to investigate the most effective stimulation method for enhancing midline theta neural oscillations in the frontal lobe, in combination with left dorsolateral prefrontal cortex iTBS, for the treatment of post-stroke depression patients. This study will include 40 post-stroke depressed patients, and each participant must meet the inclusion criteria. The first group of participants, consisting of 20 individuals, will receive the optimal combination intervention. The second group of participants will only receive iTBS stimulation, without any additional intervention strategies used in Experiment 1. Patients will undergo Hamilton Depression Scale assessment and resting state and task state EEG collection at baseline, one week after intervention, and two weeks after intervention.The primary outcome will be the Hamilton Depression Scale, with EEG-related data being analyzed as a secondary outcome. Task-oriented EEG detection will include both facial expression recognition paradigm and oddball experiment paradigm. Reaction time, accuracy, and completion status will be recorded simultaneously in the experiment. The experiment will record patients' tolerance and any adverse events that occur.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2025
CompletedStudy Start
First participant enrolled
March 30, 2025
CompletedFirst Posted
Study publicly available on registry
April 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 30, 2027
April 4, 2025
March 1, 2025
1.9 years
March 29, 2025
March 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Montgomery-Asberg Depression Rating Scale,MADRS
This scale will be the primary outcome measure for Experiment 2. Montgomery-Asberg Depression Rating Scale,MADRS: Extreme depression: MADRS \>35; Major depression: MADRS \>30; Moderate depression: MADRS \>22; Mild depression: MADRS \>12; Remission stage: MADRS \<12.
Day1
Electroencephalogram
EEG will be the main outcome measures for Experiment 1 and Experiment 2. EEG power in the delta, theta, alpha, beta band: the power spectral density (PSD) in unit\^2/Hz Functional connectivity---Phase locking value (PLV): The value of PLV ranges from 0 to 1 Event related potentials in amplitude/μV
Day 1
Secondary Outcomes (7)
Mini-mental state examination,MMSE
Day 1
Montreal Cognitive Assessment, MoCA
Day 1
Hamilton Depression Scale,HAMD
Day 1
Hamilton Anxiety Scale,HAMA
Day 1
Quick Inventory of Depressive Symptomatology Self-Report, QIDS-SR16
Day 1
- +2 more secondary outcomes
Study Arms (7)
LC TMS combined with the RECT task (Experiment1)
EXPERIMENTALLeft cerebellar single-pulse TMS stimulation combined with the RECT task
RC TMS combined with the RECT task (Experiment1)
EXPERIMENTALRight cerebellar single-pulse TMS stimulation combined with the RECT task
MC TMS combined with the RECT task (Experiment1)
EXPERIMENTALMidline cerebellar single-pulse TMS stimulation combined with the RECT task
Sham cerebellar single-pulse TMS stimulation combined with the RECT task (Experiment1)
SHAM COMPARATORSham cerebellar single-pulse TMS stimulation combined with the RECT task, The TMS coil was placed at the cerebellar site but tilted 90° to prevent effective magnetic field penetration.
Combined Stimulus Intervention group (Experiment 2)
EXPERIMENTALCombined iTBS stimulation of the dorsolateral prefrontal cortex and TMS of the cerebellum with the RECT task intervention group
iTBS treatment group(Experiment 2)
EXPERIMENTALThe group of participants will receive left dorsolateral prefrontal cortex iTBS stimulation, as well as sham cerebellar TMS stimulation and sham RECT task.
Traditional treatment group(Experiment 2)
SHAM COMPARATORThe group of participants will receive sham left dorsolateral prefrontal cortex iTBS stimulation, sham cerebellar TMS stimulation, and sham RECT task.
Interventions
The first group will receive left cerebellar single-pulse TMS stimulation combined with the RECT task. RECT refers to rostral anterior cingulate cortexr (rACC)-engaging cognitive task. The theoretical basis of this task is that when subjects are in a state of focused attention, the power of theta neural oscillations in the midline of their frontal lobe will increase. By considering the features of post-stroke depression, this study combines the emotional recognition task with the RECT task. During each trial, individuals will view 4 faces consecutively, each displaying a different expression, and they will be required to memorize the sequence of expressions. Emoticons consist of joy, sorrow, and rage. After displaying four facial expressions, a brief text flowchart will appear. Participants need to check if the sequence reflected in the flowchart matches the order in which the four facial expressions appeared. If they match, click the left mouse button; if they do not match, click the
Right cerebellar single-pulse TMS stimulation combined with the RECT task
Midline cerebellar single-pulse TMS stimulation combined with the RECT task
Sham cerebellar single-pulse TMS stimulation combined with the RECT task, The TMS coil was placed at the cerebellar site but tilted 90° to prevent effective magnetic field penetration.
The optimal stimulation protocol determined in Experiment 1 combined with stimulation of the left dorsolateral prefrontal cortex.
Subjects in the group underwent left dorsolateral prefrontal cortex iTBS stimulation, in addition to receiving sham TMS stimulation and participating in a sham RECT task. The sham RECT task involves having participants watch a continuous scroll of faces without needing to react.
The participants in this group received sham left dorsolateral prefrontal cortex iTBS stimulation, sham cerebellar TMS stimulation, and sham RECT task.
Eligibility Criteria
You may qualify if:
- Onset of stroke \<6 months ago, or \>6 months since the last stroke event;
- Age \>=18 years and \<85 years (as the probability of Vascular Cognitive Impairment increases above 85);
- Patients with damage in the middle cerebral artery territory;
- NIHSS \>4 and \<26;
- mRS score \>=2;
- Completion of CT or MRI;
- No neurological or psychiatric disorders; no impairment of consciousness; able to comply with relevant treatments; no severe cognitive dysfunction (MMSE \>=15);
- All participants are right-handed; Sign the informed consent form.
You may not qualify if:
- History of epilepsy or psychiatric disorders (including depression, anxiety, or schizophrenia);
- Severe comorbidities;
- History of medication use: benzodiazepines, baclofen, antidepressants;
- Non-compliance with the treatment plan;
- Acute-phase cerebral hemorrhage, acute infectious diseases;
- Severe suicidal tendencies in individuals with depression;
- Individuals suffering from severe headaches, high blood pressure, malignant tumors, open wounds, vascular embolism, leukopenia, etc.;
- Severe alcohol abuse;
- History of cranial surgery, individuals with metal implants in the brain;
- Individuals with an implanted cardiac pacemaker;
- NIHSS \>26, MMSE \<15;
- Any disease likely to prevent the patient from surviving more than one month;
- Pregnant individuals.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Department of Rehabilitation Medicine, the Second Affiliated Hospital of Kunming Medical University
Study Record Dates
First Submitted
March 29, 2025
First Posted
April 4, 2025
Study Start
March 30, 2025
Primary Completion (Estimated)
February 28, 2027
Study Completion (Estimated)
May 30, 2027
Last Updated
April 4, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share